United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 7 minute read Technology Industry News Broadcom (NASDAQ: AVGO) beats earnings expectations with $8.4bn AI chip revenue surge Broadcom Inc. (NASDAQ: AVGO) reports strong Q1 FY2026 results powered by AI chip demand. Discover what the numbers mean for the global AI infrastructure race. bySrinathMarch 5, 2026